Trump's government-backed prescription drug website is set to include generic medications.
President Trump on Thursday announced a drug pricing deal with Regeneron — the last of 17 manufacturers the administration pressured last year to commit to his "most favored nation" policy. Why it matters: The deals with the other companies to lower certain drug prices are being touted as one of the administration's signature health accomplishments, though Democrats question whether the confidential arrangements are really helping consumers. Driving the news: Like other deals, the agreement calls for lower prices for certain drugs offered to Medicaid, as well as to patients paying cash through the TrumpRx website. - Trump claimed the deal amounts to "the biggest cut in drug prices in the history of our country, by many percentage…
Regeneron agreed to reduce prices for its current and future medications sold to Medicaid, and to lower the price of its cholesterol drug Praluent to $225 for Americans through the TrumpRx.gov website in exchange for relief from pharmaceutical tariffs.
Trump announces a new deal with pharmaceutical company Regeneron as part of his "Most Favored Nation" initiative. It marks the 17th agreement the administration has made with major drug companies for pricing concessions. The president has also touted his TrumpRX.com platform, a direct-to-consumer website featuring more than 40 prescription drugs treating various conditions at varying discounts.
| Channel | t.me/News_Wire_Channels |
| Source | https://www.youtube.com/watch?v=Of-5J0G9qUI |
| Keywords | trumpregenerondrug-pricingmost-favored-nationhealthcare-policypharmaceuticalsprescription-drugstrumprxeconomic-policyhealthcare-reform |
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
The event is scheduled to begin at 3 p.m. Eastern and the president is expected to announce a new deal with pharmaceutical company Regeneron.
President Trump is hosting an event at the White House on Thursday afternoon centered on health care affordability. Trump is expected to announce a new deal with pharmaceutical company Regeneron, according to White House press secretary Karoline Leavitt, as part of his "Most Favored Nation" initiative. It marks the 17th agreement the administration has made with major drug companies for pricing concessions. The president has also touted his TrumpRX.com platform, a direct-to-consumer website featuring more than 40 prescription drugs treating various conditions at varying discounts. The event is scheduled to begin at 3 p.m. EDT. Watch the live video above. #trump #obamacare #healthcare
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Regeneron is the sole drugmaker among 17 large pharmaceutical companies that received letters from President Donald Trump.